Get started
Author

Marta Santaliestra

Observed names: M. Santaliestra, Marta Santaliestra Tomas
ORCID: 0000-0002-8293-5779
Observed ORCID: 0000-0002-8293-5779
OpenAlex ID: A5040942022
Toxicity of Asciminib in Real Clinical Practice: Analysis of Side Effects and Cross-Toxicity with Tyrosine Kinase Inhibitors
2023 · Lucía Pérez-Lamas, Alejandro Luna, et al. · Cancers · 35
PDF
Real world outcomes of momelotinib in myelofibrosis patients with anemia: results from the MOMGEMFIN study
2025 · Lucía Pérez-Lamas, Adrián Segura Diaz, et al. · Blood Cancer Journal · 13
PDF
Bone marrow WT1 levels in patients with myeloid neoplasms treated with 5‐azacytidine: Identification of responding patients
2019 · Marta Santaliestra, Ana Garrido, et al. · European Journal Of Haematology · 10
Clinical Characteristics and Outcomes of Patients with Primary and Secondary Myelofibrosis According to the Genomic Classification Using Targeted Next-Generation Sequencing
2023 · Marta Garrote, Mónica López-Guerra, et al. · Cancers · 6
PDF
Real-world evidence of Carfilzomib, Lenalidomide and Dexamethasone (KRD) Scheme in patients with relapsed / refractory multiple myeloma
2025 · Antoni Garcia-Guiñon, Paola Andrea Charry, et al. · Annals of Hematology · 5
PDF
Prognostic value of response to first-line hydroxyurea according to IPSET stratification in essential thrombocythemia
2024 · Marta Santaliestra, Marta Garrote, et al. · Leukemia · 5
Toxicity of Asciminib in Real Clinical Practice; Analysis of Side Effects and Cross-Intolerance with Tyrosine Kinase Inhibitors
2022 · Lucía Pérez-Lamas, Alejandro Luna, et al. · Blood · 5
Outcomes of chronic myeloid leukemia patients after therapeutic failure to conventional tyrosine kinase inhibitors and asciminib
2024 · Lucía Pérez-Lamas, Adrián Segura Díaz, et al. · Annals of Hematology · 4
PDF
Low Rate of Invasive Fungal Infections During Induction and Consolidation Chemotherapy for Adults with De Novo Acute Myeloid Leukemia Without Anti-mold Prophylaxis: Single-Center 2002–2018 Empirical/Pre-emptive Approach
2020 · Rodrigo Martino, Ana Garrido, et al. · Mycopathologia · 4
Impact of thrombosis on disease progression, cancer and mortality in patients with essential thrombocythemia and polycythemia vera
2026 · A. Angona, B. Cuevas, et al. · Blood Cancer Journal · 3
PDF
Real-World Outcomes of Momelotinib As an Alternative Therapy to Other JAK Inhibitors in Myelofibrosis Patients with Anemia
2024 · Lucía Pérez-Lamas, Adrian Segura Diaz, et al. · Blood · 3
PDF
Philadelphia-negative chronic myeloproliferative neoplasm follow-up: when the phone rings. Changes during the COVID-19 pandemic and patient satisfaction. Experience in 30 health centers in Spain
2022 · Ariana Ortuzar, María Laura Fox, et al. · Annals of Hematology · 3
Review of the risk of thrombosis or bleeding upon abrupt anagrelide discontinuation in patients with essential thrombocythemia
2022 · Marta Santaliestra, Francisca Ferrer-Marín, et al. · Annals of Hematology · 2
Prognostic Value of Response to First-Line Hydroxyurea According to Ipset Stratification in Essential Thrombocythemia
2024 · Marta Santaliestra, Marta Garrote, et al. · Blood · 1
Outcomes of Chronic Myeloid Leukemia Patients after Therapeutic Failure to Asciminib, a Multicenter Observational Study
2023 · Lucía Pérez-Lamas, Adrian Segura Diaz, et al. · Blood · 1
PDF
PB3570 Prognostic significance of arterial or venous thrombosis on disease progression, cancer and mortality in myeloproliferative neoplasms
2026 · Eduardo Arellano-Rodrigo, Anna Angona, et al. · Research and Practice in Thrombosis and Haemostasis
PDF
Low-hemoglobin Polycythemia Vera: Diagnostic Criteria and Clinico-pathological Characterization
2026 · Marta Garrote, Paula Sastre, et al. · Research Square
PDF
Treatment-free remission after bosutinib discontinuation (BOSUTFR): results from a multicenter real-world study by the Spanish CML group
2026 · R De Paz Arias, G Maortua Langdon, et al. · Annals of Hematology
Mutational profile and cardiovascular risk factors impact prognosis in triple-negative essential thrombocythemia
2026 · Gonzalo Carreño-Tarragona, Rodrigo Gil-Manso, et al. · Leukemia
PDF
Response to therapy and prognosis according to molecular characterization in CALR ‐mutated essential thrombocythemia
2026 · Marta Santaliestra, Marta Garrote, et al. · HemaSphere
Molecular predictors of anemia response to momelotinib in patients with myelofibrosis: Real-world outcomes from the momgemfin study.
2025 · Adrian Segura Diaz, Lucia Perez Lamas, et al. · Blood
P937: Carfilzomib, Lenalidomide Plus Dexamethasone (krd) in Relapsed/refractory Multiple Myeloma Patients: Update Analysis of Real-life Experience of Gemmac Group.
2023 · Antonio Garcia-Guiñon, Paola Andrea Charry, et al. · HemaSphere
P1054: Clinical Characteristics and Outcomes in 175 Patients With Myelofibrosis According to Genomic Classification Using Next-generation Sequencing
2023 · Marta Garrote Ordeig, Monica Lopez-Guerra, et al. · HemaSphere
Bone marrow fibrosis, sequence variant of asxl1, and Sjögren syndrome: A case report
2020 · Marta Santaliestra, Elena Bussaglia, et al. · Clinical Case Reports
PDF
Works count: 24
Citation count: 100
H-index: 5
I10-index: 3
Year
Topic
Type